US Stock MarketDetailed Quotes

PIRS Pieris Pharmaceuticals

Watchlist
  • 13.6000
  • -2.5300-15.69%
Close Dec 13 16:00 ET
  • 13.2600
  • -0.3400-2.50%
Post 16:03 ET
17.96MMarket Cap-1.12P/E (TTM)

Pieris Pharmaceuticals Key Stats

Pieris Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q319.520M / 7.744M--
--2023/Q220.055M / 4.019M--
May 10, 20232023/Q11.936M / 3.500M--
Mar 29, 20232022/Q45.846M / 6.511M--
Nov 2, 20222022/Q35.370M / 4.511M--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q319.520M / 7.744M--
--2023/Q220.055M / 4.019M--
May 10, 20232023/Q11.936M / 3.500M--
Mar 29, 20232022/Q45.846M / 6.511M--
Nov 2, 20222022/Q35.370M / 4.511M--

Unlock Free Earnings Estimates

Pieris Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.